Showing results (281-290 of 496) with videos related to

Sort By:
Pageof 50
BMJ Medicine|March 20, 2023
Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugsMayookha Mitra-Majumdar, John H Powers, Beatrice L Brown, et al.
JAMA Health Forum|July 7, 2023
Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021C Joseph Ross Daval, Theodore W Teng, Massimiliano Russo, et al.
Journal of General Internal Medicine|February 9, 2022
Experts' Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient CareSanket S Dhruva, Jonathan J Darrow, Aaron S Kesselheim, et al.
Mayo Clinic Proceedings|November 6, 2019
Prescription Opioid Epidemic and Trends in the Clinical Development of New Pain MedicationsThomas J Hwang, Michael S Sinha, Chintan V Dave, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017Benjamin N Rome, ChangWon C Lee, Joshua J Gagne, et al.
Health Affairs (Project Hope)|July 2, 2019
The Impact Of Price Regulation On The Availability Of New Drugs In GermanyAriel D Stern, Felicitas Pietrulla, Annika Herr, et al.
Health Affairs (Project Hope)|May 8, 2018
Evaluating The Impact Of The Orphan Drug Act's Seven-Year Market Exclusivity PeriodAmeet Sarpatwari, Reed F Beall, Abdurrahman Abdurrob, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2016
Comparative effectiveness and safety of thalidomide and lenalidomide in patients with multiple myeloma in the United States of America: A population-based cohort studyJing Luo, Joshua J Gagne, Joan Landon, et al.
JAMA|October 21, 2024
Strategies to Help Patients Navigate High Prescription Drug CostsHussain S Lalani, Catherine S Hwang, Aaron S Kesselheim, et al.
JAMA Health Forum|March 29, 2024
Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar CompetitionKimberly Feng, Massimiliano Russo, Luca Maini, et al.
Pageof 50